Mahajan Amit K, Collar Nancy, Muldowney Frances, Patel Priya P, Hogarth Douglas K, Duong Duy K
Department of Surgery, Inova Schar Cancer Institute, Inova Fairfax Hospital.
Department of Interventional Pulmonology, Inova Fairfax Hospital, Falls Church, VA.
J Bronchology Interv Pulmonol. 2024 Dec 20;32(1). doi: 10.1097/LBR.0000000000001002. eCollection 2025 Jan 1.
Bronchoscopic lung volume reduction (BLVR) is a minimally invasive procedure used to reduce shortness of breath and improve functionality in some patients with emphysema. While BLVR is often effective for improving dyspnea by causing target lobe atelectasis, the treatment effect can sometimes be lost. This study reviews the incidence of revision bronchoscopies in patients who lost or never achieved target lobe atelectasis following BLVR.
This retrospective, single-center analysis reviewed patients who underwent BLVR over a 5-year period. All patients were determined to be collateral ventilation negative by an intraprocedural Chartis system assessment. Treatment success was defined as radiographic target lobe atelectasis. For patients who underwent revision bronchoscopies, the EMR was used to review procedure notes, radiographic imaging, post-BLVR analyses, and outpatient clinic notes to collect data on the indication for revision bronchoscopy, intraprocedural observations accounting for loss of treatment effect, revision interventions performed, and outcomes of revision bronchoscopies. After a minimum of 10 postoperative days, at the discretion of the treating physician, an EBV revision bronchoscopy could be performed if target lobe atelectasis was lost or never developed after initial treatment.
Forty-three total valve revision procedures were performed, based on first, second, and third bronchoscopies combined. The most common cause for revision bronchoscopy based on the intraoperative assessment was air leaking around one or more valves from either incorrect sizing of previous valves or airway stretching in 18 revision procedures (42%). Thirty-four revision procedures (79%) were performed for loss of previous atelectasis, and 24 (70%) resulted in the redevelopment of target lobe atelectasis. Nine revision procedures (21%) were performed for lack of initial target lobe atelectasis. Two of the 9 revision procedures (22%) performed for failure to achieve initial atelectasis resulted in new target lobe atelectasis.
Post-BLVR revision bronchoscopies are necessary in ∼20% of patients for either loss of target lobe atelectasis or failure to achieve atelectasis after the initial BLVR procedure. In many cases, especially when atelectasis is lost, revision bronchoscopies can reestablish post-BLVR atelectasis.
支气管镜肺减容术(BLVR)是一种微创手术,用于减轻部分肺气肿患者的呼吸急促并改善其功能。虽然BLVR通常可通过导致目标肺叶肺不张来有效改善呼吸困难,但治疗效果有时会丧失。本研究回顾了BLVR后未实现或失去目标肺叶肺不张的患者中支气管镜再次手术的发生率。
这项回顾性单中心分析纳入了5年内接受BLVR的患者。所有患者在术中通过Chartis系统评估确定为侧支通气阴性。治疗成功定义为影像学上目标肺叶肺不张。对于接受支气管镜再次手术的患者,使用电子病历回顾手术记录、影像学检查、BLVR后分析和门诊病历,以收集有关支气管镜再次手术指征、导致治疗效果丧失的术中观察结果、实施的再次干预措施以及支气管镜再次手术结果的数据。术后至少10天,根据主治医生的判断,如果在初始治疗后目标肺叶肺不张消失或未形成,可进行EBV支气管镜再次手术。
基于首次、第二次和第三次支气管镜检查,共进行了43次瓣膜修复手术。根据术中评估,支气管镜再次手术最常见的原因是一个或多个瓣膜周围漏气,这是由于先前瓣膜尺寸不合适或气道扩张所致,在18次再次手术中出现(42%)。34次再次手术(79%)是因为先前的肺不张消失而进行的,其中24次(70%)导致目标肺叶肺不张重新出现。9次再次手术(21%)是因为最初未出现目标肺叶肺不张而进行的。9次因未实现初始肺不张而进行的再次手术中有2次(22%)导致新的目标肺叶肺不张。
约20%的患者在BLVR后需要进行支气管镜再次手术,原因是目标肺叶肺不张消失或在初始BLVR手术后未实现肺不张。在许多情况下,尤其是当肺不张消失时,支气管镜再次手术可以重新建立BLVR后的肺不张。